Comparison of the tumor immune microenvironment of primary hormone receptor-negative HER2-positive and triple negative breast cancer

被引：3

作者：

Vos, Hanne ^{[1
,2
]}

Lambein, Kathleen ^{[1
,2
]}

Richard, Francois ^{[3
]}

Marien, Bram ^{[1
,2
]}

Nevelsteen, Ines ^{[1
,2
,4
]}

Punie, Kevin ^{[4
,5
]}

Wildiers, Hans ^{[4
,5
]}

Berben, Lieze ^{[5
]}

Laenen, Annouschka ^{[6
]}

Floris, Giuseppe ^{[4
,7
]}

Desmedt, Christine ^{[3
]}

Smeets, Ann ^{[1
,2
,4
]}

机构：

[1] Katholieke Univ Leuven, Univ Hosp Leuven, Dept Surg Oncol, Leuven, Belgium

[2] Katholieke Univ Leuven, Dept Oncol, Leuven, Belgium

[3] Katholieke Univ Leuven, Lab Translat Breast Canc Res, Dept Oncol, Leuven, Belgium

[4] Univ Hosp Leuven, Multidisciplinary Breast Ctr, Leuven, Belgium

[5] Katholieke Univ Leuven, Dept Gen Med Oncol, Lab Expt Oncol, Univ Hosp Leuven, Leuven, Belgium

[6] Katholieke Univ Leuven, Leuven Biostat & Stat Bioinformat Ctr L BioStat, Leuven, Belgium

[7] Katholieke Univ Leuven, Univ Hosp Leuven, Dept Imaging & Pathol, Lab Translat Cell & Tissue Res, Leuven, Belgium

来源：

NPJ BREAST CANCER | 2021年 / 7卷 / 01期

基金：

欧洲研究理事会;

关键词：

INFILTRATING LYMPHOCYTES; FREE SURVIVAL; TRASTUZUMAB;

D O I：

10.1038/s41523-021-00332-7

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The vast majority of studies investigating immune checkpoint inhibition (ICI) in patients with breast cancer have focused on triple-negative breast cancer (TNBC). In this study, we compared the tumor immune microenvironment (TIME) between TNBC and hormone receptor-negative HER2-positive breast cancer based on a selection of immune markers at the protein level in an institutional retrospective series. Additionally, we performed a similar comparison using publicly available transcriptomics data. Altogether, the results show a comparable TIME in both groups, with possible implications for the use of ICI in patients with hormone receptor-negative HER2-positive breast tumors.

引用

页数：5

共 50 条

[31] Prognostic gene candidates for early stage hormone receptor-negative and triple-negative breast cancer
Yau, Christina
Waldman, Fred
Sninsky, John
Moore, Dan
Fan, Eugene
Esserman, Laura
Benz, Christopher
[J]. CANCER RESEARCH, 2009, 69
[32] Hydrophobic proteome analysis of triple negative and hormone-receptor- positive-her2-negative breast cancer by mass spectrometer
Lu M.
Whelan S.A.
He J.
Saxton R.E.
Faull K.F.
Whitelegge J.P.
Chang H.R.
[J]. Clinical Proteomics, 2010, 6 (3) : 93 - 103
[33] The Landmark Series: Neoadjuvant Chemotherapy for Triple-Negative and HER2-Positive Breast Cancer
Leon-Ferre, Roberto A.
Hieken, Tina J.
Boughey, Judy C.
[J]. ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (04) : 2111 - 2119
[34] SABCS 2020: update on triple-negative and metastatic HER2-positive breast cancer
Bartsch, Rupert
[J]. MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2021, 14 (03) : 247 - 251
[35] The Landmark Series: Neoadjuvant Chemotherapy for Triple-Negative and HER2-Positive Breast Cancer
Roberto A. Leon-Ferre
Tina J. Hieken
Judy C. Boughey
[J]. Annals of Surgical Oncology, 2021, 28 : 2111 - 2119
[36] Estrogen Receptor Positive and Progesterone Receptor-negative Breast Cancer: The Role of Hormone Therapy
Habibi, Mehran
Canner, Joseph
Dembinski, Robert
[J]. ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 2) : S467 - S467
[37] SABCS 2020: update on triple-negative and metastatic HER2-positive breast cancer
Rupert Bartsch
[J]. memo - Magazine of European Medical Oncology, 2021, 14 : 247 - 251
[38] Survival of triple-negative and HER2-positive breast cancer by AJCC stage.
Caggiano, V.
Bauer, K.
Parise, C.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[39] Correlation between magnetic resonance imaging and the level of tumor-infiltrating lymphocytes in patients with estrogen receptor-negative HER2-positive breast cancer
Choi, Woo Jung
Kim, Youyeon
Cha, Joo Hee
Shin, Hee Jung
Chae, Eun Young
Yoon, Ga Young
Kim, Hak Hee
[J]. ACTA RADIOLOGICA, 2020, 61 (01) : 3 - 10
[40] Implications of high tumor infiltrating lymphocytes (TIL) in HER2-positive and triple-negative breast cancer (TNBC).
Kotoula, Vassiliki
Chatzopoulos, Kyriakos
Lakis, Sotiris
Alexopoulou, Zoi
Timotheadou, Eleni
Zagouri, Flora
Pentheroudakis, George E.
Gogas, Helen
Galani, Eleni P.
Tsolaki, Eleftheria
Chrisafi, Sofia
Koutras, Angelos
Aravantinos, Gerasimos
Papakostas, Pavlos
Kosmidis, Paris A.
Pectasides, Dimitrios G.
Fountzilas, George
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)

← 1 2 3 4 5 →